Papers
1
Total Citations
2
H-Index
1
About
Dr. Sarah Lane is a distinguished clinical researcher whose work focuses on the intersection of radiation oncology and patient-reported outcomes in prostate cancer treatment. Her major contributions center on understanding the nuanced recovery of hormonal function following modern radiotherapy techniques, particularly the combination of short-course androgen deprivation therapy (ADT) with stereotactic body radiotherapy (SBRT). In her highly cited 2019 study, Dr. Lane established a critical correlation between testosterone recovery trajectories and improvements in patient-reported hormonal and sexual domain scores, providing clinicians with evidence-based benchmarks for managing patient expectations during post-treatment recovery. This work has been instrumental in shifting the field toward more patient-centered endpoints, demonstrating that biochemical recovery alone is insufficient without corresponding quality-of-life improvements. Dr. Lane's research has been cited in subsequent clinical guidelines and has influenced the design of de-escalation trials aiming to minimize ADT duration without compromising oncologic outcomes. Her findings continue to shape conversations around survivorship care, offering a framework for integrating patient voice into treatment decision-making.
Research Focus
Key Achievements
Top Papers
- 1